A Pennsylvania biotech company is planning to start injecting healthy volunteers with a potential coronavirus vaccine, after receiving regulatory clearance to start clinical testing.
Researchers plan to administer the first person today. The experimental vaccine was developed by Inovio Pharmaceuticals, with funding from the Bill and Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations.
Inovio’s candidate, called INO-4800, is the second potential coronavirus vaccine to start human trials in the US. The Massachusetts biotech Moderna started administering in mid-March for its own safety trial.